Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma.
de Groot JF, Gilbert MR, Aldape K, Hess KR, Hanna TA, Ictech S, Groves MD, Conrad C, Colman H, Puduvalli VK, Levin V, Yung WK.
de Groot JF, et al.
J Neurooncol. 2008 Oct;90(1):89-97. doi: 10.1007/s11060-008-9637-y. Epub 2008 Jun 26.
J Neurooncol. 2008.
PMID: 18581057
Free PMC article.
Clinical Trial.